The FDA Announces Two More Antacid Recalls Due to Cancer Risk

Photo of The FDA Announces Two More Antacid Recalls Due to Cancer Risk
Facebook
VKontakte
share_fav

Two more companies recalled their ranitidine drugs, generic forms of Zantac, over concerns they may contain a carcinogenic substance.

view Wired
#medication
#cancer
#fda
#drugs
#science
#science / health